Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults

Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults

Since the introduction of efficient anti-SARS-CoV-2 vaccines, the detection of antibodies becomes useful for immunological monitoring and COVID-19 control. Therefore, this longitudinal study aimed to evaluate the detection of SARS-CoV-2 antibodies in the serum and saliva of COVID-19-vaccinated adult...

Full description

Bibliographic Details
Main Authors:	Vitória Tavares Castro, Hélène Chardin, Juliana Amorim dos Santos, Gustavo Barcelos Barra, Grazielle Rodrigues Castilho, Paula Monteiro Souza, Pérola de Oliveira Magalhães, Ana Carolina Acevedo, Eliete Neves Silva Guerra
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 SARS-CoV-2 saliva antibodies neutralizing antibodies IgG
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1296603/full

Similar Items

Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review
by: Eliete Neves Silva Guerra, et al.
Published: (2022-09-01)

Influence of Caudovirales Phages on Humoral Immunity in Mice
by: Anton Chechushkov, et al.
Published: (2021-06-01)

Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
by: Anna Timofeeva, et al.
Published: (2022-03-01)

Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test
by: Hyeon Woo Shim, et al.
Published: (2022-08-01)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
by: Xu Song, et al.
Published: (2023-06-01)

The CDE region of feline Calicivirus VP1 protein is a potential candidate subunit vaccine
by: Lisha Li, et al.
Published: (2024-03-01)

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva
by: Stephan Winklmeier, et al.
Published: (2024-02-01)

The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
by: Yuxiao Wang, et al.
Published: (2023-03-01)

Follow-up study on COVID-19 survivors one year after discharge from hospital
by: Yumiao Zhao, et al.
Published: (2021-11-01)

Comparison of salivary and serum IgG antibody in diagnosis of Helicobacter Pylori
by: M.Nasrolahei (Ph.D), et al.
Published: (2003-03-01)

Toxoplasmosis: Serious disease during pregnancy
by: Baghdad Science Journal
Published: (2011-03-01)

IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
by: Lorena O. Fernandes-Siqueira, et al.
Published: (2022-11-01)

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children
by: Maya W. Keuning, et al.
Published: (2022-09-01)

COVID-19 booster enhances IgG mediated viral neutralization by human milk in vitro
by: Vivian Valcarce, et al.
Published: (2024-02-01)

Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity
by: Marija Vukčević, et al.
Published: (2024-01-01)

Placental Transfer Efficiency of Neutralizing Antibodies on SARS-CoV-2 Vaccination before and after Pregnancy in Mexican Women
by: Rebeca Martínez-Quezada, et al.
Published: (2024-01-01)

Chlamydial IgG and IgM assessment in patients with non infectious ophthalmic diseases
by: Asadi Amoli F, et al.
Published: (2008-11-01)

Seroprevalence of toxoplasma-specific antibodies in patients suspected to have active toxoplasmosis: A cross-sectional survey
by: Abbas Ali Eskandarian, et al.
Published: (2014-01-01)

Pitfalls in the Serological Diagnosis of Primary Human Cytomegalovirus Infection in Pregnancy Due to Different Kinetics of IgM Clearance and IgG Avidity Index Maturation
by: Antonella Sarasini, et al.
Published: (2021-02-01)

Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
by: Anita Siller, et al.
Published: (2024-03-01)

Natural history and pathogenesis of IgG4-related disease
by: Culver, E
Published: (2015)

Wound Healing and Mucosal Immunity during Short Mars Analog Environment Mission: Salivary Biomarkers and Its Clinical Implications
by: Balwant Rai, et al.
Published: (2012-08-01)

Salivary IgG assay to detect Helicobacter pylori infection in an Indian adult population
by: Ramya Thirumala Krishnaswamy, et al.
Published: (2012-01-01)

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
by: Savannah E. Butler, et al.
Published: (2021-01-01)

Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020
by: Yajie Yuan, et al.
Published: (2021-03-01)

The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine
by: Ana M. Espino, et al.
Published: (2024-01-01)

The value of serum neutralizing antibody in evaluating predictability of COVID-19 after recovery and the validation of vaccine
by: Bianqin Guo, et al.
Published: (2023-12-01)

Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination
by: Andrew R. Kick, et al.
Published: (2023-03-01)

Seroprevalence of dengue virus infection in Pune City in India, 2019: A decadal change
by: Kalichamy Alagarasu, et al.
Published: (2023-11-01)

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection
by: Nao Jounai, et al.
Published: (2017-02-01)

Seroepidemiology of toxoplasmosis in pregnant women referring to health centers in the city of Hamadan in 1391
by: Amirhossein Maghsood, et al.
Published: (2013-02-01)

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
by: Selen Ünlü, et al.
Published: (2024-04-01)

Kinetics IgM and IgG SARS-CoV-2 in Recovery patients with Negative Evaluation RT-PCR
by: Jusup Endang, et al.
Published: (2023-11-01)

Mycoplasma pneumoniae: IgG and IgM antibody response in presence of different antigens. Evaluation of commercial tests
by: Mariella Tonella, et al.
Published: (2011-12-01)

Prevalence of serum antibodies to TORCH infection in the first trimester of the pregnancy in Kashan, Iran
by: sareh bagheri josheghani, et al.
Published: (2015-03-01)

Prevalence of serum antibodies to TORCH infection in the first trimester of the pregnancy in Kashan, Iran
by: sareh bagheri josheghani, et al.
Published: (2015-03-01)

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
by: Yalcin Pisil, et al.
Published: (2021-06-01)

Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
by: Chunhua Luo, et al.
Published: (2021-07-01)

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
by: Marjahan Akhtar, et al.
Published: (2023-12-01)

Taenia solium metacestode immunodominant peptides recognized by IgG antibodies in cerebrospinal fluid and serum paired samples from patients with active and inactive neurocysticercosis
by: Ivanildes Solange da Costa Barcelos, et al.
Published: (2007-09-01)